Chemours (NYSE: CC) reported Q4 EPS of $0.00, $0.12 worse than the analyst estimate of $0.12. Revenue for the quarter came in at $1.3 billion versus the consensus estimate of $1.26 billion.

For earnings history and earnings-related data on Chemours (CC) click here.